Image of the Day: Scarred Hearts

Maps of diving cells before and after heart attacks in mice offer additional evidence against the existence of cardiac stem cells.

Written byAshley Yeager
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: Scar tissue (red) and dead muscle cells (pale green) accumulate in the hearts of mice after heart attack. No cells divide and develop into new muscle cells, showing that cardiac stem cells do not exist.
© HUBRECHT INSTITUTE

Cardiac stem cells, whose existence has been debated, do not exist, according to new images of scarred mouse hearts. Using molecular and genetic techniques, researchers created cell-by-cell maps of mouse hearts before and after the animals suffered heart attacks. The maps show that many new cell types—including blood vessel and immune cells—develop after the damage caused by the heart attacks. But, none of the cells are new heart muscle tissue, which means there are not stem cells native to the heart, the team reports this week in PNAS.

While no new muscle tissue develops after heart damage, fibroblasts, which are connective tissue cells, divide multiple times to develop scar tissue. That scar ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies